1.1 Microorganisms & Microbial Pathogenesis

1.1 Microorganisms & Microbial Pathogenesis

Infection preventionists (IPs) must possess a deep understanding of microbiology, taxonomy, and pathogenesis to identify pathogens, interpret laboratory reports, and break the chain of transmission. Microorganisms are categorized into distinct domain structures based on cellular organization: prokaryotes (bacteria), eukaryotes (fungi, parasites), and acellular infectious entities (viruses, prions).

1. Taxonomic Classification & Cellular Hierarchy

Bacteria are single-celled prokaryotic organisms lacking a membrane-bound nucleus or membrane-enclosed organelles. Their structural classification relies heavily on cell wall composition, shape, and metabolic oxygen requirements.

Gram-Positive vs. Gram-Negative Cell Wall Architecture

The Gram stain differentiates bacteria based on the physical and chemical properties of their cell walls.

Morphologic & Metabolic Profiles

Bacteria exhibit distinct shapes (cocci, bacilli, spirilla) and oxygen tolerances:

• Gram-Positive Cocci: Include Staphylococcus aureus (clusters, catalase-positive, coagulase-positive), Staphylococcus epidermidis (clusters, coagulase-negative), Streptococcus pneumoniae (pairs/diplococci, alpha-hemolytic), and Enterococcus faecalis/faecium (chains, gamma/variable hemolysis).
• Gram-Negative Bacilli: Encompass the family Enterobacterales (Escherichia coli, Klebsiella pneumoniae, Enterobacter cloacae, Proteus mirabilis) and non-fermenting bacilli such as Pseudomonas aeruginosa, Acinetobacter baumannii, and Stenotrophomonas maltophilia.
• Anaerobic Bacteria: Obligate anaerobes thrive in low oxygen tensions. Important species include Bacteroides fragilis (Gram-negative bacillus of intra-abdominal flora) and Clostridium species (Gram-positive bacilli).
• Spore-Forming Bacteria: Bacteria such as Clostridioides difficile and Bacillus anthracis form metabolically dormant endospores under environmental stress. Endospores possess a dense keratin-like coat resistant to desiccation, heat, ultraviolet radiation, and standard alcohol-based or quaternary ammonium disinfectants. Infection prevention requires physical removal via soap and water hand hygiene or surface decontamination using sporicidal agents (e.g., sodium hypochlorite).

2. Viral Pathogens & Structural Determinants

Viruses are obligate intracellular parasites consisting of nucleic acid (DNA or RNA) enclosed within a protein coat (capsid). Some viruses acquire a surrounding lipid bilayer membrane (envelope) derived from host cell membranes during budding.

Enveloped vs. Non-Enveloped Viruses

1. Enveloped Viruses: Possess a delicate lipid envelope containing viral glycoprotein spikes (e.g., Influenza virus, Human Immunodeficiency Virus [HIV], Hepatitis B Virus [HBV], Hepatitis C Virus [HCV], Severe Acute Respiratory Syndrome Coronavirus 2 [SARS-CoV-2], Varicella-Zoster Virus). The lipid envelope is readily disrupted by lipophilic disinfectants, detergents, and alcohol-based hand rubs (60–95% ethanol or isopropanol).
2. Non-Enveloped (Naked) Viruses: Consist only of a protein capsid (e.g., Norovirus, Rotavirus, Adenovirus, Enteroviruses, Hepatitis A Virus). Protein capsids are exceptionally stable in the environment and highly resistant to lipid solvents and alcohols. Environmental containment relies on chlorine-releasing agents or specialized high-level disinfectants.

Viral Nucleic Acid & Key Pathogens

• DNA Viruses: Generally possess double-stranded genomes with low mutation rates (e.g., Herpes simplex, Cytomegalovirus, Adenovirus, Hepatitis B). Hepatitis B virus (HBV) is a bloodborne pathogen that exhibits extreme environmental stability, remaining infectious on dry surfaces for at least 7 days.
• RNA Viruses: Predominantly single-stranded genomes subject to high error rates during replication due to lack of proofreading polymerases. Norovirus is the leading cause of epidemic acute gastroenteritis in healthcare settings, characterized by a low infectious dose (<18 viral particles), prolonged shedding, and resistance to drying. Influenza viruses undergo minor antigenic drift (point mutations in hemagglutinin/neuraminidase) causing seasonal epidemics, and major antigenic shift (reassortment of genomic segments) resulting in global pandemics.

3. Fungal Pathogens & Clinical Impact

Fungi are eukaryotic organisms with rigid cell walls composed of chitin, glucan, and mannan. Pathogenic fungi exist as yeasts (unicellular), molds (filamentous multicellular hyphae), or dimorphic fungi (yeast form in tissue at 37°C, mold form in the environment at 25°C).

• Candida albicans: Endogenous commensal yeast of the human gastrointestinal and genitourinary tracts. Causes mucosal candidiasis (thrush) and invasive bloodstream infections (candidemia) in patients with central lines or broad-spectrum antibiotic exposure.
• Candida auris: Emerging multidrug-resistant yeast posing a severe global healthcare threat. Unlike other Candida species, C. auris colonizes human skin persistently, sheds into the healthcare environment, survives on dry inanimate surfaces for weeks, and causes widespread nosocomial outbreaks. Automated laboratory platforms frequently misidentify C. auris. IPs must enforce Contact Precautions and use EPA-registered hospital disinfectants effective against C. auris (List P).
• Aspergillus species: Opportunistic environmental molds (e.g., Aspergillus fumigatus) producing lightweight airborne conidia (spores). Inhalation of conidia by severely immunocompromised hosts (e.g., allogeneic hematopoietic stem cell transplant recipients, prolonged neutropenia) leads to Invasive Pulmonary Aspergillosis (IPA). Prevention requires HEPA-filtered positive-pressure protective environments and stringent dust suppression during facility construction.

4. Parasitic Agents & Prion Disease

• Parasites: Include unicellular protozoa (Giardia lamblia, Cryptosporidium parvum) and multicellular helminths. Cryptosporidium oocysts are extremely resistant to municipal chlorination, necessitating filtration or ultraviolet disinfection in water management plans.
• Prions: Proteinaceous infectious particles devoid of nucleic acids. Prions cause Transmissible Spongiform Encephalopathies (TSEs), such as Creutzfeldt-Jakob Disease (CJD). Pathogenic prion proteins (PrP-Sc) induce conformational misfolding of normal host prion proteins (PrP-C) into insoluble beta-pleated sheet aggregates within brain tissue. Prions bind tenaciously to surgical instruments and resist standard steam autoclaving (121°C for 15 minutes) and routine chemical disinfection. Processing contaminated neurosurgical instruments requires specialized decontamination protocols combining 1N sodium hydroxide (NaOH) immersion or sodium hypochlorite followed by prolonged gravity-displacement autoclaving at 134°C.

5. Virulence Factors & Mechanisms of Pathogenicity

Pathogenicity is the capacity of a microorganism to cause disease, governed by specific virulence factors:

• Endotoxins: Lipopolysaccharide (LPS) components of Gram-negative bacterial outer membranes. Released during cell lysis or division, Lipid A binds to Toll-like receptor 4 (TLR4) on macrophages, triggering massive release of pro-inflammatory cytokines (TNF-alpha, IL-1, IL-6), leading to systemic inflammatory response syndrome (SIRS), septic shock, and disseminated intravascular coagulation (DIC).
• Exotoxins: Soluble proteins secreted by Gram-positive or Gram-negative bacteria. Examples include C. difficile Toxin A (enterotoxin) and Toxin B (cytotoxin), which disrupt intestinal epithelial cell tight junctions, and Staphylococcus aureus Toxic Shock Syndrome Toxin-1 (TSST-1), a superantigen that non-specifically cross-links MHC Class II with T-cell receptors, driving massive polyclonal T-cell activation.
• Capsular Polysaccharides: Extracellular capsular layers (Streptococcus pneumoniae, Neisseria meningitidis, Haemophilus influenzae) inhibit phagocytosis by preventing complement opsonization (C3b binding).
• Biofilm Formation: Microcolonies embedded within a self-produced extracellular polymeric substance (EPS) matrix adhering to living or inanimate surfaces (central venous catheters, urinary catheters, prosthetic valves). Biofilms impede antibiotic penetration, alter bacterial metabolic activity, and protect pathogens from host immune responses, causing refractory healthcare-associated infections.